Nowicky Pharma

		Margaretenstr. 7 A-1040 Vienna, Austria Tel.: +43-1-586 12 23 Fax: +43-1-586 89 94 nowicky@ukrin.com
	Für deutsche Version der Webseite hier anklicken

Main Page

In response to the numerous inquiries as to why the content of the website www.ukrin.com has been changed, we would like to inform you as follows:
The website was operated by the society Ukrainian Anti-Cancer Institute in Vienna with the aim of making extracts from scientific research papers on the preparation Ukrain available to the public. Although Ukrain is authorized in several countries, including Ukraine, it is not authorized in Austria. Based on this fact, the company Germania Pharmazeutika GmbH, Schuselkagasse 8, 1150 Vienna, +43-1-9823399-0, sued the single proprietorship Nowicky Pharma, which had to accept an order to cease and desist. Consequently, preventive fines in the total amount of EUR 225,000.00 were imposed. A court case on the admissibility of the preventive fines is pending. In order to avoid further fines, the website was taken off the net. We apologize for the inconvenience. In future you will be able to read excerpts from the book "Krebsmittel Ukrain - Kriminalgeschichte einer Verhinderung" (Anti-Cancer Agent Ukrain - The Crime Story of an Obstruction) by Eleonore Thun-Hohenstein at the address www.ukrin.com.
We would also like to point out that in its judgment dated 24.2.2005, Application no. 34983/02, the European Court of Human Rights found the Republic of Austria guilty of violation of Article 6 of the European Convention on Human Rights, because the authorization procedure was not concluded within a reasonable period of time.
In 2004 and 2006 Dr. Wassil Nowicky was nominated for the Nobel Prize for Chemistry.
Successes so far and registration in many countries are a clear sign. We will campaign for further registrations and keep you up to date with news.

Eleonore Thun-Hohenstein
Anticancer Pharmaceutical Ukrain. Criminal Story of a Prevention

'...One evening, a member of the secret service, Johann Wagner, turned up at Nowicky's flat and told the baffled inventor that it had been reported that the secret service of a Mediterranean country had given the order to liquidate Nowicky. However, the hired assassins had confided in the Austrian authorities...'

English version of the book you can find here
Correspondence concerning the attempt to liquidate Dr.Nowicky you can find here

Eleonore Thun-Hohenstein,
born in 1924 in Ravne in present-day Slovenia. Studied philosophy and psychology in Freiburg and Vienna.
Doctoral thesis on Max Scheler. From 1955 to 1963 at "Die Presse" newspaper, from 1960 head of the culture department.

Move to the "Wochenpresse" weekly paper in 1963, where she was head of the newly created "Science" department. Received the Ministry of Science prize for science journalism in 1973. In addition to publications in Austrian and foreign journals, author of the books: "Aristokraten" (Aristocrats) a novel, "Tiere sprechen unsere Sprache" (Animals speak our language) non-fiction, "Der Fürst" (The Prince) a biographical novel. Since 1984 independent author.

History of Nobel Prize Nomination
Letter of Professor, PhD, M.D., D.hx. id I. Nefyodov

Dear Dr. Nowicky,

As I looked at your homepage over the last few days I realised that the difficulties made for you by various parties that are described in the book "Krebsmittel Ukrain, Kriminalgeschichte einer Verhinderung" ("Cancer Drug Ukrain, a Crime Story of Hindrance") are continuing.

I find it more than merely shocking that, due to legal action by a company named Germania, you have to pay fines instead of gaining the recognition you deserve.

As a scientist I have occupied myself with the preparation Ukrain for many years. In 2004 I was asked by the Nobel Prize Committee to put forwards names of important scientists in the field of chemistry. In submitting the documentation in which I proposed you for the Nobel Prize for Chemistry there were many incongruities. I sent in the documentation several times but it never arrived at the Nobel Prize Committee. When the Committee was asked about this by phone, they told that in the hundred-year history of the Nobel Prize, documentation has never before disappeared. As a result, instead of you, two biologists from Israel, Aaron Ciechanover and Avram Hershko and Irwin Rose - a biologist from the USA - were awarded the Nobel Prize.

http://nobelprize.org/chemistry/laureates/2004/index.html

I ask you to publish the documentation sent to you on your homepage.

Head of Department of Biochemistry and Laboratory
of Biochemistry of Biologically Active Substances
Yanka Kupala State University of Grodno,
Chairman of Belarusian Biochemical Society
Professor, PhD, M.D., D.hx. id I. Nefyodov

Letter of Professor, PhD, M.D., D.hx. id I. Nefyodov
Invitation to submit proposals for the award of The Nobel Prize in Chemistry for 2004
Statement
Letter of Prof. Nefyodov to the Nobel Committee for Chemistry
Letter of Prof. Nefyodov to The Times
Letter of Prof. Nefyodov to Neue Zürcher Zeitung

Proceedings at the European Court

The European Court of Human Rights has adjudged Austria to have taken an over-long period of time in the approval process for the medicament Ukrain. This verdict (Application No. 34983/02) can be found on the website of the ECHR:

Case of Nowicky v. Austria (Application no. 34983/02)

A new complaint was lodged with the European Court of Human Rights on 2 March 2006 on account of unlawful rejection of an approval application. This complaint has been accepted by the ECHR.

The originals of the above-mentioned documents can be found here:
The ECHR verdict against Austria (Application No. 34983/02)
Complaint to the ECHR on 20.1.2006
New complaint to the ECHR on 2.3.2006
Confirmation of receipt from the ECHR (German language)
Action filed on 06.02.2008 at the Court of First Instance of the European Union

Application for Orphan Medicinal Product Designation
Answer to the negative Opinion of EMEA on Ukrain, dated 12th of June 2007
Opinion of the Committee for Orphan Medicinal Products on Orphan Medicinal Product Designation
Action filed on 06.02.2008 at the Court of First Instance of the European Union

Imprint